Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析

◆英語タイトル:Blueprint Medicines Corp (BPMC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH325832FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralsetinib) against non-small cell lung cancer (NSCLC) in adults. It is investigating fisogatinib for the treatment of advanced hepatocellular carcinoma; BLU-263 targeting indolent systemic mastocytosis. Blueprint Medicines is also advancing pralsetinib inhibitor against RET (Ret Proto-Oncogene) modified medullary thyroid carcinoma and other solid tumors; and avapritinib to treat advanced systemic mastocytosis. The company utilizes its discover engine which combines bioinformatics and drug design capabilities to develop its medicines. Blueprint Medicines is headquartered in Cambridge, Massachusetts, the US.

Blueprint Medicines Corp Key Recent Developments

Apr 05,2021: Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday, April 12, 2021
Mar 10,2021: Blueprint Medicines to showcase scientific leadership in precision oncology and Hhematology at AACR Annual Meeting 2021
Feb 17,2021: Blueprint medicines reports fourth quarter and full year 2020 financial results

This comprehensive SWOT profile of Blueprint Medicines Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Blueprint Medicines Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Blueprint Medicines Corp – Key Information
Blueprint Medicines Corp – Overview
Blueprint Medicines Corp – Key Employees
Blueprint Medicines Corp – Key Employee Biographies
Blueprint Medicines Corp – Key Operational Heads
Blueprint Medicines Corp – Major Products and Services
Blueprint Medicines Corp – History
Blueprint Medicines Corp – Company Statement
Blueprint Medicines Corp – Locations And Subsidiaries
Blueprint Medicines Corp
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Blueprint Medicines Corp – Business Description
Blueprint Medicines Corp – Corporate Strategy
Blueprint Medicines Corp – SWOT Analysis
SWOT Analysis – Overview
Blueprint Medicines Corp – Strengths
Blueprint Medicines Corp – Weaknesses
Blueprint Medicines Corp – Opportunities
Blueprint Medicines Corp – Threats
Blueprint Medicines Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Blueprint Medicines Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Blueprint Medicines Corp, Key Information
Blueprint Medicines Corp, Key Ratios
Blueprint Medicines Corp, Share Data
Blueprint Medicines Corp, Major Products and Services
Blueprint Medicines Corp, History
Blueprint Medicines Corp, Key Employees
Blueprint Medicines Corp, Key Employee Biographies
Blueprint Medicines Corp, Key Operational Heads
Blueprint Medicines Corp, Other Locations
Blueprint Medicines Corp, Subsidiaries
Blueprint Medicines Corp, Key Competitors
Blueprint Medicines Corp, SWOT Analysis
Blueprint Medicines Corp, Ratios based on current share price
Blueprint Medicines Corp, Annual Ratios
Blueprint Medicines Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mycenax Biotech Inc (4726):企業の財務・戦略的SWOT分析
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …
  • Sunnova Energy Corporation:電力:M&Aディール及び事業提携情報
    Summary Sunnova Energy Corporation (Sunnova Energy) is engaged in providing solar power services to homeowners. The company is involved in installing and generating power. It offers solar service agreements such as EZ Pay PPA, PPA, EZ own plan, and solar lease plan. In addition, the company offers s …
  • Montefiore Medical Center-医療機器分野:企業M&A・提携分析
    Summary Montefiore Medical Center (MMC) is a healthcare service provider that offers clinical services. The center offers services such as allergy and immunology, orthopaedics, dentistry and oral surgery, dermatology, endocrinology, digestive and liver diseases, neurological surgery, otorhinolaryngo …
  • Cohort Plc
    Cohort Plc - Strategy, SWOT and Corporate Finance Report Summary Cohort Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Australian Securities & Investments Commission:企業の戦略的SWOT分析
    Australian Securities & Investments Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Rollprint Packaging Products Inc.:企業の戦略・SWOT・財務情報
    Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report Summary Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Merge Healthcare Incorporated:企業のM&A・事業提携・投資動向
    Merge Healthcare Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merge Healthcare Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Stantec Inc:企業のM&A・事業提携・投資動向
    Stantec Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stantec Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Korea Zinc Co Ltd (010130):企業の財務・戦略的SWOT分析
    Summary Korea Zinc Co Ltd (Korea Zinc) operates as a mineral smelting company. The company develops and acquires gold, silver, cobalt, zinc, and copper and other rare and base metal properties. It operates a production facility, Onsan Refinery in Ulju-gun region of Ulsan in South Korea. Korea Zinc’s …
  • Enerjisa Enerji AS (ENJSA):企業の財務・戦略的SWOT分析
    Enerjisa Enerji AS (ENJSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • ComOps Limited (COM):企業の財務・戦略的SWOT分析
    ComOps Limited (COM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Suburban Propane Partners, L.P.:企業の戦略・SWOT・財務分析
    Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Daily Mail & General Trust plc (DMGT):企業の財務・戦略的SWOT分析
    Daily Mail & General Trust plc (DMGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Alstom SA (ALO)-エネルギー分野:企業M&A・提携分析
    Summary Alstom SA (Alstom) is a manufacturer of transportation vehicles. It designs, develops and manufactures rail transport equipment, systems, services and signaling for urban, suburban, regional and main line passenger transportation, and for freight transportation. The company offers a wide ran …
  • TOWER Limited:企業の戦略・SWOT・財務分析
    TOWER Limited - Strategy, SWOT and Corporate Finance Report Summary TOWER Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • State Atomic Energy Corporation Rosatom-エネルギー分野:企業M&A・提携分析
    Summary State Atomic Energy Corporation Rosatom (ROSATOM), the Russian Federation national nuclear corporation, is a nuclear company that integrates nuclear companies and R&D institutions which operate in the civilian and defense sectors. It provides a variety of nuclear services that range from ura …
  • OBI Pharma Inc (4174)-医療機器分野:企業M&A・提携分析
    Summary OBI Pharma Inc (OBI Pharma) is a developer of therapies for the treatment of cancer and infectious diseases. The company develops its pipeline products through its carbohydrate synthesis discovery platform. Its flagship products include OBI-822, an active immunotherapy which is intended for …
  • Oceaneering International Inc (OII):企業の財務・戦略的SWOT分析
    Oceaneering International Inc (OII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Dassault Systemes SA:企業の戦略・SWOT・財務情報
    Dassault Systemes SA - Strategy, SWOT and Corporate Finance Report Summary Dassault Systemes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Metalico Inc:企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆